PSI Offers To Stop Clinical Trial Delays In Hematology And Beyond
ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a full service Contract Research Organization, known for On-Time, On-Budget, On-Promise Clinical Trial Delivery, invites biotechnology companies and CROs to join forces in bringing novel treatments to patients sooner.
PSI will be attending the upcoming 57th ASH (American Society of Hematology) Annual Meeting in Orlando. Biotechnology sponsors are invited to join the #StopTrialDelays discussion at booth 1663 beginning Saturday, December 5th through Monday, December 7th. PSI extends the invitation to all biotech companies who are planning clinical trials in the area of hematology and oncohematology and for whom predictability and quality of clinical trial timelines are of paramount value.
PSI will be attending the upcoming 57th ASH (American Society of Hematology) Annual Meeting in Orlando. Biotechnology sponsors are invited to join the #StopTrialDelays discussion at booth 1663 beginning Saturday, December 5th through Monday, December 7th. PSI extends the invitation to all biotech companies who are planning clinical trials in the area of hematology and oncohematology and for whom predictability and quality of clinical trial timelines are of paramount value.